Alt-R™ CRISPR Reagents Enable High Efficiencies Of Editing And Homology Directed Repair (HDR) In Induced Pluripotent Stem Cells (iPSCs)

This content is brought to you by Integrated DNA Technologies, a Danaher Operating Company.

Precise genome editing in iPSCs remains limited by variability in reagents and workflows, making consistent HDR outcomes difficult to achieve. Optimized CRISPR components, including engineered nucleases, guide RNAs, and donor oligos, can significantly improve editing efficiency and accuracy across multiple loci. HDR performance can be further elevated with targeted enhancement strategies, such as small molecules and protein-based inhibitors that modulate DNA repair pathways. A streamlined, high-throughput analysis workflow supports rapid, targeted NGS-based quantification of edits, enabling clearer insights into editing success and reproducibility. Together, these advances offer a more reliable path to precise genome modification in therapeutically relevant cells.

See how refined design parameters and integrated workflows can help bring consistency and scalability to your CRISPR applications.